News

Make your portfolio income-producing and provide valuable cash for your daily life. Read more on how to turn your portfolio ...
Shionogi will pay BioVersys $6.3 million for developing BV500, BioVersys's drug candidate for non-tuberculous mycobacteria.
Aside from the rare superhuman baby able to bench press their body weight from birth, most little ones require a baby gym.
There's no one-size-fits-all answer when it comes to major life milestones. In fact, when the Pew Research Center asked more ...